SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-029985
Filing Date
2021-03-01
Accepted
2021-03-01 16:10:33
Documents
67
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm211065d1_10k.htm 10-K 997000
2 EXHIBIT 31 tm211065d1_ex31.htm EX-31 15516
3 EXHIBIT 32 tm211065d1_ex32.htm EX-32 7402
  Complete submission text file 0001104659-21-029985.txt   6343822

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20201130.xml EX-101.INS 1414539
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20201130.xsd EX-101.SCH 58342
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20201130_cal.xml EX-101.CAL 35576
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20201130_def.xml EX-101.DEF 254249
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20201130_lab.xml EX-101.LAB 496258
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20201130_pre.xml EX-101.PRE 407410
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-55535 | Film No.: 21697814
SIC: 2834 Pharmaceutical Preparations